SCHEMBL21936720

SCHEMBL21936720

C=Cc1cc(C=N)c(NC)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21872399 0.78 — —
SCHEMBL26024421 0.76 NPC1 (0.30) —
SCHEMBL21936271 0.76 — —
SCHEMBL19431554 0.74 — —
SCHEMBL18052979 0.70 APP (0.35) —
SCHEMBL25859507 0.70 POLB (0.39) —
SCHEMBL16404877 0.68 HTT (0.40) —
SCHEMBL24195802 0.68 POLB (0.40) —
SCHEMBL22513765 0.67 IDO1 (0.32) —
SCHEMBL21021267 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
Send feedback